1
|
Tsai JH, Tsai TF. A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis. Dermatitis 2024; 35:24-42. [PMID: 37205852 DOI: 10.1089/derm.2022.0096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
Dupilumab, a monoclonal antibody targeting interleukin-4 antibody, is approved for use in many type 2 inflammatory diseases, including atopic dermatitis. It is generally well tolerated with no need of routine laboratory monitoring. However, several adverse events have been reported during real-world practice and in pivotal trials. We conducted a systematic literature research of the PubMed, Medline, and Embase databases to identify articles recording the clinical manifestation and potential pathogenesis of these adverse events with interests (AEIs) to dermatologists. In total, 547 cases from 134 studies have developed 39 AEIs 1 day to 2.5 years after dupilumab treatment. The most common AEIs are facial and neck dermatitis (299 cases), psoriasis (70 cases), arthralgia (56 cases), alopecia (21 cases), cutaneous T cell lymphoma (19 cases), severe ocular diseases (19 cases), and drug eruption (6 cases). Most of the AEIs recorded in this review resolved or improved after dupilumab discontinuation or the addition of another treatment, whereas 3 of the cases died of severe AEI. The potential pathogenesis included T help type 1 (Th1)/T help type 2 (Th2) imbalance, Th2/T help type 17 (Th17) imbalance, immune reconstitution, hypersensitivity reaction, transient hypereosinophilia related, and Th1 suppression. Clinicians should be alert of these AEIs for timely diagnosis and appropriate treatment.
Collapse
Affiliation(s)
- Jun-Hong Tsai
- From the Department of Medical Education, National Taiwan University Hospital, Taipei, Taiwan
| | - Tsen-Fang Tsai
- Department of Dermatology, National Taiwan University Hospital & National Taiwan University, College of Medicine, Taipei, Taiwan
| |
Collapse
|
2
|
Heidemeyer K, May Lee M, Cazzaniga S, Yawalkar N, Naldi L. Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies. PSORIASIS (AUCKLAND, N.Z.) 2023; 13:33-58. [PMID: 37772169 PMCID: PMC10522454 DOI: 10.2147/ptt.s400402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/20/2023] [Accepted: 09/16/2023] [Indexed: 09/30/2023]
Abstract
Palmoplantar pustulosis (PPP) is a chronic, relapsing, inflammatory disease that can occur alone or in association with arthritis. There is still controversy about whether it should be separated from psoriasis or classified as pustular psoriasis. Furthermore, drug-induced paradoxical PPP is a special variant of PPP that differs from classic PPP in several ways. Treatment of PPP is still challenging, and there are a number of treatment-resistant cases. This review summarizes the risk factors for the development of PPP and the currently available treatment modalities. Female sex, smokers or ex-smokers, obesity, thyroid dysfunction, and treatment with a tumor necrosis factor (TNF)-α inhibitor have been identified as risk factors for the disease's development, severity, and course. Topical treatments and phototherapy are effective for some patients and are used as a first-line or adjuvant treatment modality. Conventional treatments including retinoids and fumaric acid show good effects and can increase the efficacy of treatment with psoralen + ultraviolet light therapy (PUVA). Ciclosporin is fast acting, but relapse mostly occurs immediately after cessation. TNF-α inhibitors are efficient, and an even better response can be achieved with IL-17 and IL-23 blockers as well as apremilast. The effect of Janus kinase inhibitors seems to be promising according to case reports, but further investigations with larger cohorts are needed.
Collapse
Affiliation(s)
- Kristine Heidemeyer
- Department of Dermatology, Inselspital University Hospital of Bern, Bern, Switzerland
- Centro Studi GISED, Bergamo, Italy
| | - Marco May Lee
- Section of Dermatology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy
| | - Simone Cazzaniga
- Department of Dermatology, Inselspital University Hospital of Bern, Bern, Switzerland
- Centro Studi GISED, Bergamo, Italy
| | - Nikhil Yawalkar
- Department of Dermatology, Inselspital University Hospital of Bern, Bern, Switzerland
| | - Luigi Naldi
- Centro Studi GISED, Bergamo, Italy
- Dermatology Department, S. Bortolo Hospital, Vicenza, Italy
| |
Collapse
|
3
|
Ran D, Chen S, Lu X, Zhou G, Zhang Z. Unique Lesions on the Dorsum of the Hands: A Quiz. Acta Derm Venereol 2023; 103:adv00885. [PMID: 36892510 PMCID: PMC10012469 DOI: 10.2340/actadv.v103.5358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2022] [Accepted: 02/14/2023] [Indexed: 03/10/2023] Open
Abstract
Abstract is missing (Quiz)
Collapse
Affiliation(s)
- Delin Ran
- Department of Dermatology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Veneorology, Shandong First Medical University & Shandong Academy of Medical Sciences.
| | - Shengli Chen
- Department of Dermatology, Shandong Provincial Hospital for Skin Diseases& Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University&Shandong Academy of Medical Sciences
| | - Xianmei Lu
- Department of Dermatology, Shandong Provincial Hospital for Skin Diseases& Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University&Shandong Academy of Medical Sciences
| | - Guizhi Zhou
- Department of Dermatology, Shandong Provincial Hospital for Skin Diseases& Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University&Shandong Academy of Medical Sciences
| | - Zhaoxia Zhang
- Department of Dermatology, Shandong Provincial Hospital for Skin Diseases& Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University&Shandong Academy of Medical Sciences
| |
Collapse
|
4
|
Patchinsky A, Kalita V, Muller P, Petitpain N. Response to ‘Eruptive keratoacanthomas associated with dupilumab therapy’. SKIN HEALTH AND DISEASE 2023. [DOI: 10.1002/ski2.197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/06/2023]
Affiliation(s)
| | - Victoria Kalita
- Service de dermatologie CHR Metz‐Thionville Hôpital Bel Air Thionville France
| | - Philippe Muller
- Service de dermatologie CHR Metz‐Thionville Hôpital Bel Air Thionville France
| | | |
Collapse
|
5
|
Moghadam P, Herms F, Baroudjian B, Tetu P, Delyon J, Jouenne F, Boisson M, Louveau B, Mourah S, Brunet-Possenti F, Duverger L, Gounant V, Lebbé C, Basset-Seguin N. Eruptive squamous cell carcinomas following an acute skin inflammatory disease: A series of four cases. J Eur Acad Dermatol Venereol 2023; 37:e119-e121. [PMID: 35993817 DOI: 10.1111/jdv.18559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2022] [Accepted: 08/08/2022] [Indexed: 12/15/2022]
Affiliation(s)
- Parna Moghadam
- Dermatology Department, Université Paris-Cité, INSERM 976, Saint Louis Hospital, Paris, France
| | - Florian Herms
- Dermatology Department, Université Paris-Cité, INSERM 976, Saint Louis Hospital, Paris, France
| | - Barouyr Baroudjian
- Dermatology Department, Université Paris-Cité, INSERM 976, Saint Louis Hospital, Paris, France
| | - Pauline Tetu
- Dermatology Department, Université Paris-Cité, INSERM 976, Saint Louis Hospital, Paris, France
| | - Julie Delyon
- Dermatology Department, Université Paris-Cité, INSERM 976, Saint Louis Hospital, Paris, France
| | - Fanélie Jouenne
- Tumor Genomics and Pharmacology Department, Université Paris-Cité, INSERM UMR-S 976, Saint Louis Hospital, Paris, France
| | - Marie Boisson
- Tumor Genomics and Pharmacology Department, Université Paris-Cité, INSERM UMR-S 976, Saint Louis Hospital, Paris, France
| | - Baptiste Louveau
- Tumor Genomics and Pharmacology Department, Université Paris-Cité, INSERM UMR-S 976, Saint Louis Hospital, Paris, France
| | - Samia Mourah
- Tumor Genomics and Pharmacology Department, Université Paris-Cité, INSERM UMR-S 976, Saint Louis Hospital, Paris, France
| | - Florence Brunet-Possenti
- Virology Department, Université de Paris-Cité, INSERM UMR 1137 IAME, Bichat Hospital, Paris, France
| | - Lucie Duverger
- Pathology Department, Saint Louis Hospital, Paris, France
| | - Valérie Gounant
- Thoracic Oncology Department, Université de Paris-Cité, CIC-1425 Inserm, Bichat-Claude Bernard Hospital, Cancer Institute-AP-HP Nord, Paris, France
| | - Céleste Lebbé
- Dermatology Department, Université Paris-Cité, INSERM 976, Saint Louis Hospital, Paris, France
| | - Nicole Basset-Seguin
- Dermatology Department, Université Paris-Cité, INSERM 976, Saint Louis Hospital, Paris, France
| |
Collapse
|
6
|
Long XH, Jiang HS, Lai JD, Liu YH, Wang WL. Erythema multiforme (EM)-like drug eruption associated with dupilumab treatment: report of an unusual case. Dermatol Ther 2022; 35:e15792. [PMID: 36038515 DOI: 10.1111/dth.15792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2022] [Revised: 08/14/2022] [Accepted: 08/26/2022] [Indexed: 11/26/2022]
Affiliation(s)
- Xiao-Huan Long
- Department of Dermatology, Guangdong Medical University, Zhanjiang, Guangdong, China
| | - Hui-Shan Jiang
- Department of Dermatology, Guangdong Medical University, Zhanjiang, Guangdong, China
| | - Jun-Dong Lai
- Department of Dermatology, Yangjiang People's Hospital affiliated to Guangdong Medical University, Yangjiang, Guangdong, China
| | - Yan-Huan Liu
- Department of Dermatology, Yangjiang People's Hospital affiliated to Guangdong Medical University, Yangjiang, Guangdong, China
| | - Wei-Liang Wang
- Department of Dermatology, Yangjiang People's Hospital affiliated to Guangdong Medical University, Yangjiang, Guangdong, China
| |
Collapse
|